Home/Filings/4/0001179110-21-002628
4//SEC Filing

HAASER CHARLES B 4

Accession 0001179110-21-002628

CIK 0001121702other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 1:47 PM ET

Size

5.7 KB

Accession

0001179110-21-002628

Insider Transaction Report

Form 4
Period: 2021-03-01
HAASER CHARLES B
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2021-03-01$16.03/sh+1,950$31,2594,725 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    3,306
Footnotes (2)
  • [F1]The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 09/01/2021 and the remaining 50% on 03/01/2022.
  • [F2]Shares acquired as Company matching contributions under the Yield10 Bioscience, Inc. 401(k) Plan.

Issuer

YIELD10 BIOSCIENCE, INC.

CIK 0001121702

Entity typeother

Related Parties

1
  • filerCIK 0001230903

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 1:47 PM ET
Size
5.7 KB